BackDecision Diagnostics Overview

Decision Diagnostics Common Stock

Track Decision Diagnostics's common stock ($360K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$357871.00
↑ 11.94% YoYΔ $38164.00 vs prior year quarter

Peer trimmed avg / median

Loading

Decision Diagnostics Common Stock History

Loading

Decision Diagnostics vs. peers: Common Stock Comparison

Loading

Decision Diagnostics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Decision Diagnostics (DECN) FAQ

The latest common stock for DECN is $360K as of September 2021. That compares with $320K in the prior-year period — up 11.9% year over year. Investors often review this figure alongside Decision Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, DECN's common stock moved from $320K to $360K — a 11.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Decision Diagnostics's operating scale or balance-sheet position.

A common stock figure of $360K for DECN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DECN's common stock ($360K), review year-over-year change from $320K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.